Shattuck Labs, Inc. logo

Shattuck Labs, Inc.

NASDAQ:STTK

Overview | Financials
Company Name Shattuck Labs, Inc.
Symbol STTK
Currency USD
Price 3.5
Market Cap 167,045,550
Dividend Yield 0%
52-week-range 1.33 - 11.76
Industry Biotechnology
Sector Healthcare
CEO Dr. Taylor H. Schreiber M.D., Ph.D.
Website https://www.shattucklabs.com

An error occurred while fetching data.

About Shattuck Labs, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that

Related Stocks

OncoCyte Corporation logo

OncoCyte Corporation

OCX

3.19 USD

MediciNova, Inc. logo

MediciNova, Inc.

MNOV

2.1 USD

MDxHealth SA logo

MDxHealth SA

MDXH

2.375 USD

Olema Pharmaceuticals, Inc. logo

Olema Pharmaceuticals, Inc.

OLMA

11.83 USD

Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPR

18.63 USD

Werewolf Therapeutics, Inc. logo

Werewolf Therapeutics, Inc.

HOWL

2.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD